The magnets built into certain Apple iPhones can cause significant issues with cardiac implantable electronic devices (CIEDs), according to a new analysis in the Journal of the American Heart Association. …

Rates of out-of-hospital cardiac arrest (OHCA) increased significantly during the early months of the COVID-19 pandemic. OHCA outcomes were also much worse during that same time period, making a tough situation even more chaotic for…

After years of recommending fish oil supplements to patients as a way to combat cardiovascular disease (CVD), a Pennsylvania cardiologist has reversed course and now fears that they may be harmful.

…

iRhythm Technologies, a San Francisco-based digital health company focused on diagnosing cardiac arrhythmias, has gained two new FDA clearances—one for its new-look Zio monitor and another for its advanced AI algorithm. …

Following U.S. politics can lead to a significant increase in cardiac arrhythmias, according to a new analysis published in the Journal of the American Heart Association.

The study’s authors…

Treatment with finerenone can help limit new-onset atrial fibrillation (AFib) among patients with chronic kidney disease (CKD) and Type 2 diabetes (T2D), according to new data presented at ACC.21, the American College of Cardiology’s…

Drinking alcohol makes an immediate impact on a person’s heart rhythm, according to new data presented May 17 at ACC.21, the American College of Cardiology’s 70th annual scientific session. Even just one glass can double the…

The FDA has announced that Abbott is recalling more than 60,000 Assurity and Endurity implantable pacemakers due to a risk of moisture causing electrical shorts that lead to significant complications.

…

Stage 1 and stage 2 hypertension are both associated with a heightened risk of heart failure, atrial fibrillation (AFib), myocardial infarction (MI) and stroke, according to new data published in Circulation.…

Nearly 20% of patients with dementia also have atrial fibrillation (AFib), a combination that typically results in anticoagulants being prescribed to reduce the risk of stroke.

When the patient has…

Fish oil supplements are associated with a heightened risk of atrial fibrillation (AFib) among certain high-risk patients, according to a new meta-analysis published in European Heart Journal: Cardiovascular Pharmacotherapy.[…

Abbott is launching a new clinical trial designed to improve care for patients with both atrial fibrillation (AFib) and heart failure with preserved ejection fraction (HFpEF).

The TAP-CHF trial is…

Researchers have uncovered new clues about why subtle changes in potassium levels can cause a person to experience serious heart rhythm issues. The group also found a way to potentially alleviate such issues, sharing their findings in…

Catheter ablation provides more value as a first-line treatment for paroxysmal atrial fibrillation (AFib) than antiarrhythmic medications, according to a new meta-analysis published in JAMA Cardiology.

…

Annual foot exams provide clinicians with a valuable opportunity to screen diabetic patients for atrial fibrillation (AFib), according to new data presented at EHRA 2021, a virtual scientific congress of the European Society of…

Marijuana users with a cardiac arrhythmia are much more likely to die when hospitalized, according to new data presented at EHRA 2021, a virtual scientific congress of the European Society of Cardiology (ESC).

…

The U.S. Preventive Services Task Force (USPSTF) has determined that there is not enough evidence to make an official recommendation on screening for atrial fibrillation (AFib) among asymptomatic adults 50 years old and older. In 2018…

Rhythm Therapeutics, a Chicago-based healthcare technology company, has received a grant for up to $3.67 million to ramp up work on a new gene therapy treatment for atrial fibrillation (AFib). The technique involves identifying…

The FDA has announced that Medtronic is recalling multiple implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) due to an “unexpected and rapid decrease in battery life.” This is…

SGLT2 inhibitors are associated with a significant reduction in atrial arrhythmias and sudden cardiac death in patients with Type 2 diabetes (T2D), according to new findings published in Heart Rhythm.

…

Updating old protocols helped a team of specialists improve the quality of care they provide for atrial fibrillation (AFib) patients. The group shared its story in a new analysis for JACC: Clinical Electrophysiology.…